All In Biotech

Free tool

FAERS Monitor: Augmentin '125'

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050575 or its brand name (Augmentin '125', Amoxicillin, Clavulanate Potassium). Reports on generic versions are filed under their own applications.

Reports

27,162

Serious

21,127

78% of reports

Hospitalization

13,410

Death reported

2,624

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea1,873
  • drug hypersensitivity1,824
  • nausea1,449
  • dyspnoea1,421
  • pyrexia1,395
  • fatigue1,292
  • pneumonia1,204
  • vomiting1,173
  • rash1,031
  • pain991
  • headache947
  • acute kidney injury860
  • drug ineffective858
  • pruritus858
  • asthenia845

Reports by year received

View as table
YearReports
2004563
2005450
2006205
2007142
2008140
2009716
2010673
2011869
2012927
20131,030
20141,246
20151,602
20162,143
20171,954
20182,378
20192,414
20202,029
20211,337
20221,405
20231,423
20241,386
20251,228
2026898

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,026,997 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug hypersensitivitySignal1,8247.47.010,013
acute kidney injurySignal8604.44.12,236
pyrexiaSignal1,3953.13.02,046
pneumoniaSignal1,2042.92.71,500
diarrhoeaSignal1,8732.32.21,337
dyspnoea1,4211.91.8669
vomiting1,1731.91.8539
rash1,0311.81.7397
asthenia8451.71.6270
pruritus8581.71.6268
nausea1,4491.41.3185
fatigue1,2921.31.285
pain9911.21.251
headache9471.21.124
drug ineffective8580.50.5447

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.